States seeking to regulate pharmacy benefit managers (PBMs) won an important victory on Thursday when the U.S. Supreme Court ruled 8-0, rejecting a challenge to a law the state of Arkansas passed in 2015 to put restrictions on PBMs. The ruling could allow states to regulate PBMs, as Darrel Rowland reported for The Columbus Dispatch.
As coronavirus infections rise nationwide, health care journalists have an important role in explaining the science behind the development, safety and effectiveness of COVID-19 vaccines, said Francis S. Collins, M.D., Ph.D., the director of the National Institutes of Health.
As the Nov. 18 keynote speaker at AHCJ’s Journalism Summit on Infectious Disease, Collins gave a stark warning for journalists and all Americans about the need to recognize the value of the vaccines as they are rolled out in the coming months. Continue reading
The timeless advice sometimes attributed to Deep Throat or Bob Woodard and Carl Bernstein to “follow the money” certainly applies to COVID-19.
For reporters looking for local stories, follow the money doled out by the National Institutes of Health for COVID-19 research. Most recently, the National Cancer Institute, which received $306 million from Congress through the Coronavirus Aid, Relief, and Economic Security Act, announced the first grants and contracts to researchers to form the Serological Sciences Network for COVID-19. Continue reading
While there is rightfully much concern about the COVID-19 (aka coronavirus) becoming a pandemic (see Bara Vaida’s excellent tip sheet on covering the virus), let’s not forget we’re in the middle of flu season, another disease that is potentially fatal for older adults. While COVID-19 is deadlier, flu is much more prevalent.
Flu activity is high in the U.S. and expected to continue for weeks, according to CDC’s Weekly U.S. Influenza Surveillance Report for the week ending Feb. 15, 2020. You can see a breakout by age groups for Influenza A and B strains here. CDC estimates at least 29 million flu illnesses, 280,000 hospitalizations and 16,000 deaths from flu so far this season. Continue reading
Hospitalized older adults who take atypical, or second-generation, antipsychotics for delirium were at increased risk of death from cardiopulmonary arrest, according to a recent study by researchers in Boston.
Despite these known risks, antipsychotic drugs frequently are used to treat or prevent delirium. Delirium (sudden confusion or a rapid change in mental state) affects 15% to 26% of hospitalized older adults. It can lead those affected to harm themselves or others, or otherwise interfere with medical care. Continue reading
Experts on aging are sounding the alarm about another U.S. drug crisis: Too many older adults taking too many medications.
This trend is leading to a surge in adverse drug events (ADE) over the past two decades. The rate of emergency department visits by older adults for ADEs doubled between 2006 and 2014 — a problem as serious as the opioid crisis but whose scope appears to remain virtually invisible to families, patients, policymakers and many clinicians, according to a recent report by the Lown Institute, a nonprofit think tank in Brookline, Mass. Continue reading